Glycoprotein IV (GPIV; CD36 or GPIIIb) is a cell surface glycoprotein that has been proposed as mediating a number of physiologically important processes such as the adhesion of platelets to thrombospondin (TSP) and collagen, the cytoadherence of Plasmodium falciparum-infected erythrocytes, and the TSP-dependent interaction of monocytes with platelets and macrophages. Because platelets of the Naka-negative phenotype have recently been shown to lack detectable GPIV, their availability offered the opportunity to test directly these hypotheses regarding its adhesive functions. It has been found that Naka-negative platelets and monocytes do not support cytoadherence of P falciparum-infected erythrocytes. Naka-negative platelets are deficient in the initial stages of their adhesion to fibrillar collagen and this defect is most marked under Mg2+-free conditions. Finally, the ability of Naka-negative platelets to bind TSP before or after activation is unimpaired as compared with normal controls. These results do not support a role for GPIV as the TSP receptor. © 1991 by The American Society of Hematology.
CITATION STYLE
Tandon, N. N., Ockenhouse, C. F., Greco, N. J., & Jamieson, G. A. (1991). Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood, 78(11), 2809–2813. https://doi.org/10.1182/blood.v78.11.2809.bloodjournal78112809
Mendeley helps you to discover research relevant for your work.